Last Updated: May 10, 2026

Details for Patent: 6,455,533

Name: Drug Patent Intelligence for US Patent 6455533
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,455,533

Title:	Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
Abstract:	The invention concerns pharmaceutical compositions for oral administration, comprising an active substance belonging to the family of substituted benzhydrylpiperazines and at least a cyclodextrin.
Inventor(s):	Domenico Fanara, Monique Berwaer, Philippe Nolf, Henri Vranckx, Michel Deleers
Assignee:	UCB SA
Application Number:	US09/446,735
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 6,455,533

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,455,533

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Belgium	9700572	Jul 03, 1997

PCT Information
PCT Filed	July 02, 1998	PCT Application Number:	PCT/BE98/00100
PCT Publication Date:	January 14, 1999	PCT Publication Number:	WO99/01133

International Family Members for US Patent 6,455,533

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	224717	⤷ Start Trial
Australia	727140	⤷ Start Trial
Australia	8201598	⤷ Start Trial
Belgium	1011251	⤷ Start Trial
Brazil	9810495	⤷ Start Trial
Canada	2294783	⤷ Start Trial
China	1150900	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.